Home > Insider Trading > Filing (0001213900-20-040310)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1690080	180 Life Sciences Corp.	ATNF	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1033308	Marlene Krauss	30 Park Place, Suite 64B New York NY 10007		No	No	Yes	No
1706868	Kbl Iv Sponsor Llc	30 Park Place, Suite 64B New York NY 10007		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-11-25	12,182	$2.78	2,571,556	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-11-23	60,633	$3.26	2,583,738	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-11-19	33,445	$2.12	2,644,371	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-11-18	6,700	$2.31	2,677,816	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-11-17	3,300	$2.26	2,684,516	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.